Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...
Artera, the Los Altos, California-based developer of tools to diagnose cancer, has launched the first artificial intelligence (AI) test to guide patients in making informed decisions between active ...
A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
ABERDEEN PROVING GROUND, Maryland – Keeping an accurate and organized account of all test and evaluation (T&E) assets across the U.S. Army Test and Evaluation Command (ATEC) enterprise isn’t easy.
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today an update to the ArteraAI Prostate Test ...
Handler, Abram; Larsen, Kai R.; Hackathorn, Richard. Large language models present new questions for decision support. International Journal of Information Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback